Beating both EPS and sales estimates typically has a positive short-term impact on a company's stock price, as it indicates better-than-expected financial health and operational performance. However, the year-on-year decline in both metrics might temper investor enthusiasm, suggesting a cautious optimism in the stock's short-term outlook.